PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'IRCCS Centro Neurolesi Bonino Pulejo, C.da Casazza, 98124 Messina, Italy.\', \'Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.\', \'Department of Microbiology and Immunology, Brody Medical Sciences Building, East Carolina University, Greenville, NC 27834, USA.\', \'Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud Universidad de Guadalajara, 44340 Guadalajara, Mexico.\', \'University Center for Health Science, Department of Molecular Biology and Genomics, University of Guadalajara, Jalisco 49000, Mexico.\', \'Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy. Electronic address: ferdinic@unict.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1359-6446(21)00480-310.1016/j.drudis.2021.11.002
?:hasPublicationType
?:journal
  • Drug discovery today
is ?:pmid of
?:pmid
?:pmid
  • 34763066
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.008
?:rankingScore_hIndex
  • 150
is ?:relation_isRelatedTo_publication of
?:title
  • The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34763066>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34763066>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all